$103.75 +6.40 (%) Vertex Pharmaceuticals Inc - NASDAQ

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. Midday Gainers From September 19 - Alibaba Group Holding Ltd, Concur Technologies, Inc. And More

    Benzinga | Sep. 19, 2014 | 14:13PM EST
  2. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD | Aug. 8, 2014 | 16:45PM EST
  3. Stocks Gain, Techs Take Lead; Autohome, BitAuto Top IBD 50

    IBD | Aug. 4, 2014 | 10:28AM EST
  4. Vertex Is Poised For An Earnings Breakout

    Benzinga | Jul. 23, 2014 | 15:56PM EST
  5. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD | Jul. 3, 2014 | 17:08PM EST
  6. Analyst Concerns On Vertex's Approved Drug

    Benzinga | Jun. 25, 2014 | 09:14AM EST
  7. Benzinga's Top Downgrades

    Benzinga | Jun. 25, 2014 | 08:00AM EST
  8. Vertex Soars On Drug Study

    IBD | Jun. 24, 2014 | 18:55PM EST
  9. Utility Sector Rises; Elizabeth Arden Shares Slide Over 3.6%

    Benzinga | Jun. 24, 2014 | 15:15PM EST
  10. Micron Gains On Upbeat Earnings; Elizabeth Arden Shares Slide

    Benzinga | Jun. 24, 2014 | 12:36PM EST
  11. Nasdaq Hits 14-Year High; Facebook Breaks Out

    IBD | Jun. 24, 2014 | 11:54AM EST
  12. Deutsche Bank Reiterates Buy on Vertex Pharmaceuticals Following Press Release

    Benzinga | Jun. 24, 2014 | 11:36AM EST
  13. Vertex Cystic Fibrosis Success Quells Street's Doubts

    IBD | Jun. 24, 2014 | 11:31AM EST
  14. Bernstein Weighs In On Vertex Move

    Benzinga | Jun. 24, 2014 | 10:58AM EST
  15. Benzinga's Volume Movers

    Benzinga | Jun. 24, 2014 | 10:41AM EST
  16. Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Misses Estimates

    Benzinga | Jun. 24, 2014 | 10:28AM EST
  17. Stocks Hitting 52-Week Highs

    Benzinga | Jun. 24, 2014 | 10:20AM EST
  18. Morning Market Movers

    Benzinga | Jun. 24, 2014 | 09:40AM EST
  19. Stocks Poised For Soft Start; Vertex Rockets In Premarket

    IBD | Jun. 24, 2014 | 09:00AM EST
  20. Why Are Vertex Pharmaceuticals Up More Than 50 Percent?

    Benzinga | Jun. 24, 2014 | 08:27AM EST
  21. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 24, 2014 | 08:07AM EST
  22. Indexes End With Small Gains; Tesla Drives Higher

    IBD | Jun. 16, 2014 | 16:25PM EST
  23. Vertex Shares Hit Hard On Trial Concerns

    Benzinga | Jun. 16, 2014 | 13:39PM EST
  24. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 16, 2014 | 08:16AM EST
  25. Health Care Sector in an Upward Climb in June

    GuruFocus | Jun. 12, 2014 | 16:21PM EST
  26. For The Record

    IBD | May. 2, 2014 | 18:58PM EST
  27. Vertex Pharmaceuticals

    IBD | May. 1, 2014 | 18:54PM EST
  28. Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours

    IBD | Apr. 9, 2014 | 17:13PM EST
  29. House Probe Of Gilead's Sovaldi Price Hits Biotechs

    IBD | Mar. 21, 2014 | 17:00PM EST
  30. Gilead Pricing Probed By House; Biotech Stocks Drop

    IBD | Mar. 21, 2014 | 12:29PM EST
  31. Dow, S&P 500 Up, Nasdaq Slips; Drugmakers Falling Hard

    IBD | Mar. 21, 2014 | 10:31AM EST
  32. BioMed Realty Trust Leases Space To Life Science Firms

    IBD | Mar. 19, 2014 | 17:05PM EST
  33. Stocks Open Higher, Turn Mixed After Employement Report

    IBD | Mar. 7, 2014 | 10:31AM EST
  34. Revenue Growth: Focus On Healthcare Stocks

    YCharts | Feb. 25, 2014 | 11:50AM EST
  35. Enanta Joins Big Leagues With Hepatitis C Drug

    IBD | Jan. 7, 2014 | 19:15PM EST
  36. Vertex drug trial results mixed

    IBD | Dec. 19, 2013 | 19:01PM EST
  37. Vertex Cystic Fibrosis Trial Has Good, Bad News

    IBD | Dec. 19, 2013 | 11:12AM EST
  38. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 19, 2013 | 08:27AM EST
  39. Vertex Pharma Says Phase 3 Study Results of Ivacaftor Did Not Meet Primary Endpoint

    Benzinga | Dec. 19, 2013 | 07:33AM EST
  40. Trade Idea of the Day: Short Vertex

    Benzinga | Dec. 11, 2013 | 15:36PM EST
  41. Nasdaq Leads Stocks Higher; Archer Daniels Deal Blocked

    IBD | Nov. 29, 2013 | 12:25PM EST
  42. US Stock Futures Edge Lower Ahead Of FOMC Minutes, Economic Data

    Benzinga | Nov. 20, 2013 | 07:00AM EST
  43. Vertex Sells INCIVO Product Royalty Rights to Janssen Pharmaceutica for $152M

    Benzinga | Nov. 20, 2013 | 05:46AM EST
  44. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga | Nov. 12, 2013 | 16:41PM EST
  45. Vertex Drug, Fastest Blockbuster, Quickly Fading

    YCharts | Oct. 31, 2013 | 18:33PM EST
  46. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, PCYC)

    Benzinga | Oct. 25, 2013 | 15:36PM EST
  47. Vertex Announces Oral Selective JAK3 Inhibitor VX-509 Shows Statistically Significant Improvement in RA Phase 2b Study

    Benzinga | Oct. 18, 2013 | 17:45PM EST
  48. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga | Oct. 11, 2013 | 14:33PM EST
  49. J&J Buys Glaxo Drug In Hunt For All-Oral HCV Therapy

    IBD | Oct. 8, 2013 | 11:31AM EST
  50. Stocks Post Broad, Soft Losses; Amgen, Vertex Drag On Nasdaq

    IBD | Oct. 7, 2013 | 12:00PM EST
Trading Center